• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢孟多及其他抗生素的细菌发生率与敏感性的合作研究(作者译)

[Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].

作者信息

de Vega J C, Pais J R, del Tánago A G

出版信息

Med Clin (Barc). 1980 May 25;74(10):387-94.

PMID:7412431
Abstract

A total of 44 medical centers participated in a cooperative study on nosocomial infections. Percentages of Gram-negative, Gram-positive and anaerobic germs isolated during 30 alternate-days for 3 months were 80.35 percent, 17.25 percent and 0.52 percent, respectively. Activity of cefamandole and cefalotin against Gram-positive bacteria was very similar, and both antibiotics showed a low number of resistances. On the contrary, against Gram-negative strains the activity of cefamandole was definitely superior to that of cefalothin, but it was similar when compared to that of gentamicin. In many instances, cefamandole may be a valid alternative in treating hospital-acquired infections (except for Pseudomonas).

摘要

共有44个医疗中心参与了一项关于医院感染的合作研究。在3个月内每隔一天进行一次为期30天的采样,分离出的革兰氏阴性菌、革兰氏阳性菌和厌氧菌的百分比分别为80.35%、17.25%和0.52%。头孢孟多和头孢噻吩对革兰氏阳性菌的活性非常相似,两种抗生素的耐药菌株数量都很少。相反,对于革兰氏阴性菌株,头孢孟多的活性明显优于头孢噻吩,但与庆大霉素相比则相似。在许多情况下,头孢孟多可能是治疗医院获得性感染(除假单胞菌外)的有效替代药物。

相似文献

1
[Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].头孢孟多及其他抗生素的细菌发生率与敏感性的合作研究(作者译)
Med Clin (Barc). 1980 May 25;74(10):387-94.
2
["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].头孢孟多、头孢噻吩、头孢西丁和头孢呋辛对医院分离的肠杆菌科细菌和金黄色葡萄球菌的“体外”活性(作者译)
Pathol Biol (Paris). 1979 Dec;27(10):649-54.
3
A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin.一项关于多种细菌对头孢噻吩、头孢孟多、妥布霉素和庆大霉素敏感性的多中心研究。
S Afr Med J. 1977 Nov 5;52(20):798-800.
4
Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.头孢孟多、头孢西丁、头孢呋辛和头孢噻吩的体外活性比较
Scand J Infect Dis Suppl. 1978(13):88-93.
5
[In vitro and in vivo antimicrobial activity of cefuroxime cefamandole and cephalexin on freshly isolated strains of Gram-positive and Gram-negative bacteria].
Boll Soc Ital Biol Sper. 1981 Jul 15;57(13):1450-6.
6
Compared sensitivities of 532 bacterial strains to six cephalosporins.
Int J Clin Pharmacol Res. 1983;3(3):195-201.
7
[Activity of new cephalosporins against polyresistant bacterial strains].
Minerva Med. 1983 Mar 10;74(9-10):427-31.
8
[Activity of cefamandole against enterobacteria resistant to cephalosporins (author's transl)].头孢孟多对耐头孢菌素肠杆菌的活性(作者译)
Nouv Presse Med. 1979 Oct 15;8(39):3157-60.
9
The in vitro activity of cefamandole against 3312 bacterial isolates. A Norwegian multicentre study.头孢孟多对3312株细菌分离株的体外活性。一项挪威多中心研究。
NIPH Ann. 1980 Dec;3(2):141-7.
10
[In vitro testing of newer cephalosporins (author's transl)].新型头孢菌素的体外试验(作者译)
Infection. 1979;7 Suppl 2:S225-7. doi: 10.1007/BF01641128.